Puma Biotechnology reported $167.75M in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 717.77M 19.84M
Agios Pharmaceuticals AGIO:US $ 1702.56M 652.55M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Amgen AMGN:US $ 19099M 2200M
Arena Pharmaceuticals ARNA:US $ 990.44M 131.17M
Array Technologies Inc ARRY:US 330.21M 44.66M
Biogen BIIB:US $ 7183.7M 464.2M
Biomarin Pharmaceutical BMRN:US $ 2357.84M 69.07M
Bluebird Bio BLUE:US $ 903.53M 194.01M
Cerulean Pharma CERU:US $ 14.06M 4.46M
Clovis Oncology CLVS:US $ 296.35M 43.84M
Daiichi Sankyo 4568:JP Y 1233697M 34723M
Esperion Therapeutics ESPR:US $ 275.17M 2.6M
Exelixis EXEL:US $ 1593.25M 158.98M
Gilead Sciences GILD:US $ 14498M 1220M
Glaxosmithkline GSK:US $ 17566M 958M
Intercept Pharmaceuticals ICPT:US $ 493.1M 5.54M
Macrogenics MGNX:US $ 367M 7.72M
Mirati Therapeutics MRTX:US $ 1278.09M 25.42M
Moderna Inc MRNA:US 10.97B 734M
Novartis NOVN:VX 23.81B 1.61B
Ptc Therapeutics PTCT:US $ 1066.23M 56.13M
Puma Biotechnology PBYI:US $ 167.75M 3.99M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M
Sangamo Biosciences SGMO:US $ 554.06M 52.88M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Seattle Genetics SGEN:US $ 3098.51M 5.18M
Spectrum Pharmaceuticals SPPI:US $ 165.71M 3.5M
Takeda 4502:JP Y 2476458M 236435M
Ultragenyx Pharmaceutical RARE:US $ 949.49M 121.44M
Vanda Pharmaceuticals VNDA:US $ 446.65M 25.43M
Vertex Pharmaceuticals VRTX:US $ 8457.51M 81.79M
YTE INCY:US $ 2620.06M 170.09M